Related Experiment Video
Updated: Jun 16, 2026

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
Published on: May 16, 2015
Choline Kinetics in Neonatal Liver, Brain and Lung-Lessons from a Rodent Model for Neonatal Care
Wolfgang Bernhard1, Marco Raith2, Anna Shunova1
1Department of Neonatology, University Children's Hospital, Tübingen University Hospital, 72076 Tübingen, Baden-Wuerttemberg, Germany.
Insights
Neonatal rats rapidly convert dietary choline into phosphatidylcholine (PC) for growth. The liver supplies PC to the brain and lungs, highlighting choline
Area of Science:
- Biochemistry
- Nutritional Science
- Developmental Biology
Background:
- Choline is crucial for fetal and preterm infant development, essential for phosphatidylcholine (PC) synthesis and one-carbon metabolism.
- Choline metabolism in vital organs during rapid neonatal growth remains poorly understood.
- Understanding choline's role is critical for determining optimal nutritional requirements in vulnerable populations.
Purpose of the Study:
- To investigate the kinetics of exogenous D9-choline and its metabolites in neonatal rat organs.
- To elucidate the pathways of choline utilization, including PC synthesis and betaine formation.
- To determine organ-specific uptake and distribution of choline metabolites.
Main Methods:
- Intraperitoneal injection of D9-choline chloride (50 mg/kg) into 14-day-old rats.
- Sacrifice of animals at 1.5, 6, and 24 hours post-injection.
- Analysis of D9-choline metabolites in liver, plasma, brain, and lung tissue using tandem mass spectrometry.
Main Results:
- D9-PC and D9-betaine were significant metabolites within 1.5 hours in all analyzed organs.
- D9-PC peaked early in all organs but showed distinct kinetics: decreasing in liver/lung, but increasing in brain/lung from 6-24h.
- The liver appears to supply PC to the brain and lung via plasma, with subsequent organ-specific acyl remodeling, while betaine rapidly enters the one-carbon pool.
Conclusions:
- Exogenous choline is rapidly converted to PC in neonatal rat organs, with the liver acting as a key supplier to the brain and lung.
- Organotypic acyl remodeling of PC occurs after uptake, indicating complex metabolic handling.
- A significant portion of choline is converted to betaine, impacting one-carbon metabolism and choline requirement calculations.
Abstract:
Choline requirements are high in the rapidly growing fetus and preterm infant, mainly serving phosphatidylcholine (PC) synthesis for parenchymal growth and one-carbon metabolism via betaine. However, choline metabolism in critical organs during rapid growth is poorly understood. Therefore, we investigated the kinetics of D9-choline and its metabolites in the liver, plasma, brain and lung in 14 d old rats. Animals were intraperitoneally injected with 50 mg/kg D9-choline chloride and sacrificed after 1.5 h, 6 h and 24 h. Liver, plasma, lungs, cerebrum and cerebellum were analyzed for D9-choline metabolites, using tandem mass spectrometry. In target organs, D9-PC and D9-betaine comprised 15.1 ± 1.3% and 9.9 ± 1.2% of applied D9-choline at 1.5 h. D9-PC peaked at 1.5 h in all organs, and decreased from 1.5-6 h in the liver and lung, but not in the brain. Whereas D9-labeled PC precursors were virtually absent beyond 6 h, D9-PC increased in the brain and lung from 6 h to 24 h (9- and 2.5-fold, respectively) at the expense of the liver, suggesting PC uptake from the liver via plasma rather than local synthesis. Kinetics of D9-PC sub-groups suggested preferential hepatic secretion of linoleoyl-PC and acyl remodeling in target organs. D9-betaine showed rapid turnover and served low-level endogenous (D3-)choline synthesis. In conclusion, in neonatal rats, exogenous choline is rapidly metabolized to PC by all organs. The liver supplies the brain and lung directly with PC, followed by organotypic acyl remodeling. A major fraction of choline is converted to betaine, feeding the one-carbon pool and this must be taken into account when calculating choline requirements.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism

